In addition to low sensitivity, the poor specificity inherent in only using AFP as a diagnostic screening tool for HCC is reflected in the many other medical conditions that can lead to elevated serum levels, including 15~58% of patients with CH and 11~47% with LC, responsible for high false positive rates [12,13,14]. This evidence concerns the gene AFP and hepatocellular carcinoma.